FXTAS presents with upregulation of the cytokines IL12 and TNFα

被引:9
|
作者
Dufour, Brett D. [1 ,2 ,3 ]
Amina, Sarwat [1 ,4 ]
Martinez-Cerdeno, Veronica [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Davis, Dept Pathol & Lab Med, Sch Med, Sacramento, CA USA
[2] Inst Pediat Regenerat Med, Sacramento, CA USA
[3] Shriners Hosp Children Northern Calif, Sacramento, CA USA
[4] Univ Calif Davis, Med Invest Neurodev Disorders MIND Inst, Sacramento, CA 95817 USA
关键词
FXTAS; FMR1; gene; Premutation; Neurodegeneration; TREMOR/ATAXIA SYNDROME; CNS;
D O I
10.1016/j.parkreldis.2020.11.026
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Fragile X Tremor and Ataxia Syndrome is a progressive neurodegenerative disorder that develops in some FMR1 premutation carriers. The objective of this study is to characterize how cytokine levels are altered in the FXTAS brain. Methods: Fresh frozen cerebellar tissue from FXTAS cases and controls was homogenized and analyzed for 12 different cytokines using a commercially available ELISA panel. Results: Relative to controls, FXTAS cases showed large and significant increases in the cytokines IL-12 and TNF alpha. There were large but non-significant increases in the levels of IL-2, IL-8, and IL-10 in FXTAS cases. The cytokines IL-1A, IL-1B, IL-4 IL-6, IL-17A, IFN gamma, and GM-CSF were not different between FXTAS and control subjects. Conclusions: For the first time, we demonstrate an increase in the pro-inflammatory cytokines TNF alpha and IL-12 in the FXTAS brain, both of which are implicated in the pathogenesis of Multiple Sclerosis, another neurodegenerative disorder that predominantly consists of white matter disease.
引用
收藏
页码:117 / 120
页数:4
相关论文
共 50 条
  • [31] IL12 PREVENTS AUTOIMMUNITY IN A MURINE MODEL OF SLE
    VIA, CS
    RUS, V
    GATELY, M
    FINKELMAN, FD
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S63 - S63
  • [32] IL1-β IL-6 IL12, TNF-α and TNF-β produced by peripheral blood monocytes and subsets of dendritic cells in multidrug-resistant pulmonary tuberculosis
    Santos, P
    Morgado, JM
    Pratas, R
    Figueiredo, C
    Crespo, I
    Laranjeira, P
    Freitas, A
    Paiva, A
    Domingos, A
    Regateiro, F
    Segorbe-Luis, A
    GENES AND IMMUNITY, 2004, 5 : S73 - S73
  • [33] UNDERSTANDING THE ROLE OF THE IL12/IL35 BALANCE IN SJOGREN SYNDROME
    Fogel, O.
    Riviere, E.
    Seror, R.
    Nocturne, G.
    Ly, B.
    Boudaoud, S.
    Gottenberg, J. -E.
    Dubost, J. -J.
    Le Guern, V.
    Dieude, P.
    Chanson, P.
    Nititham, J.
    Taylor, K.
    Criswell, L.
    Mariette, X.
    Miceli-Richard, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 948 - 948
  • [34] Serum pro-inflamatory cytokine levels tnf-a, IL12, IL22 and IL23 in patients with psoriasis and metabolic syndrome
    Brito, J.
    Sandoval, A. K.
    Fafutis, M.
    Villanueva, G.
    Alvarado, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 48 - 49
  • [35] Influence of IL12 on the maturation of human naive T cells
    Delespesse, G
    Wu, CY
    Shu, U
    Byun, DG
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 461 - 464
  • [36] Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12
    Lewis, Nuruddeen D.
    Sia, Chang Ling
    Kirwin, Katherine
    Haupt, Sonya
    Mahimkar, Gauri
    Zi, Tong
    Xu, Ke
    Dooley, Kevin
    Jang, Su Chul
    Choi, Bryan
    Boutin, Adam
    Grube, Andrew
    McCoy, Christine
    Sanchez-Salazar, Jorge
    Doherty, Michael
    Gaidukov, Leonid
    Estes, Scott
    Economides, Kyriakos D.
    Williams, Douglas E.
    Sathyanarayanan, Sriram
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (03) : 523 - 534
  • [37] COMBINED IL12 AND ANTIANGIOGENIC TREATMENT OF EXPERIMENTAL CEREBRAL METASTASES
    Kirsch, Matthias
    Martin, Klaus D.
    Bertram, Aiko
    Uckermann, Ortrud
    Leipnitz, Elke
    Weigel, Patrick
    Temme, Achim
    Schackert, Gabriele
    Geiger, Kathrin
    NEURO-ONCOLOGY, 2011, 13 : 7 - 7
  • [38] Determination of correlation between cytokines IL 6, IL8, IL10, IL12, IL17 and severity of hepatocellular carcinoma in patients having hepatitis C
    Ahmad, Ishtiaq
    Hamidullah
    Ashraf
    Ali, Murad
    Hussain, Manzoor
    Din, Rehman Ud
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (12) : 2078 - 2085
  • [39] IL12, a direct stimulator and indirect inhibitor of haematopoiesis - Commentary
    Brunda
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 514 - 514
  • [40] The role of IL12 in helper T-cell differentiation
    Perez, VL
    Lederer, JA
    Carniel, E
    Lichtman, A
    Abbas, AK
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 477 - 480